<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02472873</url>
  </required_header>
  <id_info>
    <org_study_id>0062-15</org_study_id>
    <nct_id>NCT02472873</nct_id>
  </id_info>
  <brief_title>Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas</brief_title>
  <acronym>EASLETE</acronym>
  <official_title>Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas - a Prospective Case Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of aspiration and sclerotherapy during
      laparoscopy using 95% ethanol for the treatment of endometriomas, compared to the standard
      cystectomy treatment - a prospective case control study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women who are candidates for elective laparoscopy for the treatment of ovarian ensometriomas
      will be assigned to one of two groups - a) standard cystectomy treatment, b) aspiration and
      sclerotherapy using 95% ethanol. The women will be introduced with both operative options and
      they will choose which one they prefer. After an elaborate explanation about the study they
      will sign an informed consent form. the following data will be collected prior the operation:
      age, gravity &amp; parity, operative history, general medical history, the cyst size, AMH (Anti
      Mullerian Hormone), AFC (Antral Follicle Count), symptoms related to endometriosis (through a
      questionnaire), fertility history including any fertility treatment in the past and planned
      pregnancy after the operation.

      The laparoscopy will take place in Meir Medical Center. in the study group the cyst content
      will be aspirated and flushed with normal saline. 95% sterile ethanol will be instilled into
      the cyst through a foley catheter. Ethanol will be left in the cyst for a maximum of 15 min
      then aspirated as completely as possible following normal saline flushing. In the control
      group we will follow the standard treatment which is cystectomy.

      The women will be followed 4 and 6 months after the surgery.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endometrioma recurrence rate</measure>
    <time_frame>up to 6 months after the laparoscopy</time_frame>
    <description>Ultrasound examination that demonstrate the presence/lack of ovarian cyst with sonographic features of endometrioma in the ovary where the sclerotherapy took place.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of surgery</measure>
    <time_frame>intraoperative</time_frame>
    <description>the time from insertion of the first trocar until closing of the abdominal wall.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>during the surgery and until one month after the surgery.</time_frame>
    <description>infection, excessive bleeding, injury to other abdominal organs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of efficacy of the treatment by questionnaire</measure>
    <time_frame>4 months and 6 months after the laparoscopy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ovarian reserve</measure>
    <time_frame>4 months and 6 months after the laparoscopy</time_frame>
    <description>Anti mullerian hormone (AMH) and antral follicle count (AFC) measurement 4 months and 6 months after the laparoscopy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Endometrioma</condition>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>study group - sclerotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aspiration and Sclerotherapy of endometriomas.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group - cystectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cystectomy of endometriomas.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aspiration and Sclerotherapy of endometriomas.</intervention_name>
    <description>Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas</description>
    <arm_group_label>study group - sclerotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cystectomy of endometriomas.</intervention_name>
    <description>cystectomy of endometriomas during laparoscopy</description>
    <arm_group_label>control group - cystectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ethanol</intervention_name>
    <arm_group_label>study group - sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with endometrial cyst â‰¥ 4 cm.

          -  candidates for elective laparoscopy due to endometriosis.

          -  age 18-45 years

        Exclusion Criteria:

          -  endometrial cyst &lt; 4 cm.

          -  an emergency surgery.

          -  age &lt;18 or &gt;45

          -  women with a history of tubal ovarian abscess (TOA).

          -  high index of suspision for ovarian malignancy.

          -  ethanol sensitivity.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Josephy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Meir medical center</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Koike T, Minakami H, Motoyama M, Ogawa S, Fujiwara H, Sato I. Reproductive performance after ultrasound-guided transvaginal ethanol sclerotherapy for ovarian endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2002 Oct 10;105(1):39.</citation>
    <PMID>12270563</PMID>
  </reference>
  <reference>
    <citation>Suganuma N, Wakahara Y, Ishida D, Asano M, Kitagawa T, Katsumata Y, Moriwaki T, Furuhashi M. Pretreatment for ovarian endometrial cyst before in vitro fertilization. Gynecol Obstet Invest. 2002;54 Suppl 1:36-40; discussion 41-2. Review.</citation>
    <PMID>12441659</PMID>
  </reference>
  <reference>
    <citation>Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB. Management of ovarian endometriomas. Hum Reprod Update. 2002 Nov-Dec;8(6):591-7. Review.</citation>
    <PMID>12498427</PMID>
  </reference>
  <reference>
    <citation>Shaw RW. Treatment of endometriosis. Lancet. 1992 Nov 21;340(8830):1267-71. Review.</citation>
    <PMID>1359330</PMID>
  </reference>
  <reference>
    <citation>Busacca M, Chiaffarino F, Candiani M, Vignali M, Bertulessi C, Oggioni G, Parazzini F. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am J Obstet Gynecol. 2006 Aug;195(2):426-32.</citation>
    <PMID>16890551</PMID>
  </reference>
  <reference>
    <citation>Zanetta G, Lissoni A, Dalla Valle C, Trio D, Pittelli M, Rangoni G. Ultrasound-guided aspiration of endometriomas: possible applications and limitations. Fertil Steril. 1995 Oct;64(4):709-13.</citation>
    <PMID>7672139</PMID>
  </reference>
  <reference>
    <citation>Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):187-91. Japanese.</citation>
    <PMID>3283269</PMID>
  </reference>
  <reference>
    <citation>Kafali H, Yurtseven S, Atmaca F, Ozardali I. Management of non-neoplastic ovarian cysts with sclerotherapy. Int J Gynaecol Obstet. 2003 Apr;81(1):41-5.</citation>
    <PMID>12676392</PMID>
  </reference>
  <reference>
    <citation>Bret PM, Atri M, Guibaud L, Gillett P, Seymour RJ, Senterman MK. Ovarian cysts in postmenopausal women: preliminary results with transvaginal alcohol sclerosis. Work in progress. Radiology. 1992 Sep;184(3):661-3.</citation>
    <PMID>1509048</PMID>
  </reference>
  <reference>
    <citation>Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001 Jan;72(1):35-9.</citation>
    <PMID>11146075</PMID>
  </reference>
  <reference>
    <citation>Hsieh CL, Shiau CS, Lo LM, Hsieh TT, Chang MY. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009 Jun;91(6):2709-13. doi: 10.1016/j.fertnstert.2008.03.056. Epub 2008 Jun 20.</citation>
    <PMID>18571165</PMID>
  </reference>
  <reference>
    <citation>Takuma N, Sengoku K, Pan B, Wada K, Yamauchi T, Miyamoto T, Ohsumi D, Ishikawa M. Laparoscopic treatment of endometrioma-associated infertility and pregnancy outcome. Gynecol Obstet Invest. 2002;54 Suppl 1:30-4; discussion 34-5.</citation>
    <PMID>12441658</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2015</study_first_submitted>
  <study_first_submitted_qc>June 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2015</study_first_posted>
  <last_update_submitted>June 15, 2015</last_update_submitted>
  <last_update_submitted_qc>June 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>Dana Josephy</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>endometrioma</keyword>
  <keyword>endometriosis</keyword>
  <keyword>sclerotherapy</keyword>
  <keyword>ethanol</keyword>
  <keyword>aspiration</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

